<code id='43C2F4D7B2'></code><style id='43C2F4D7B2'></style>
    • <acronym id='43C2F4D7B2'></acronym>
      <center id='43C2F4D7B2'><center id='43C2F4D7B2'><tfoot id='43C2F4D7B2'></tfoot></center><abbr id='43C2F4D7B2'><dir id='43C2F4D7B2'><tfoot id='43C2F4D7B2'></tfoot><noframes id='43C2F4D7B2'>

    • <optgroup id='43C2F4D7B2'><strike id='43C2F4D7B2'><sup id='43C2F4D7B2'></sup></strike><code id='43C2F4D7B2'></code></optgroup>
        1. <b id='43C2F4D7B2'><label id='43C2F4D7B2'><select id='43C2F4D7B2'><dt id='43C2F4D7B2'><span id='43C2F4D7B2'></span></dt></select></label></b><u id='43C2F4D7B2'></u>
          <i id='43C2F4D7B2'><strike id='43C2F4D7B2'><tt id='43C2F4D7B2'><pre id='43C2F4D7B2'></pre></tt></strike></i>

          focus

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Changes to biosimilar regulatory framework must prioritize patients
          Changes to biosimilar regulatory framework must prioritize patients

          JUANMABROMATA/AFPviaGettyImagesBiosimilarsarenolongeranewanduntestedclassofmedicines.Today,theyprovi

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          CDC's new outbreak response network to include Northeastern

          MarkSchiefelbein/APNortheasternUniversityhasbeenselectedforaleadingroleinanewnationalnetworkformedto